Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

Rhône. Axoltis Pharma Raises €18 Million to Fight Charcot Disease

Summary by ledauphine.com
BioTech in Lyon wants to accelerate the development of its drug candidate in the fight against Charcot disease.

2 Articles

ledauphine.comledauphine.com
Center

Rhône. Axoltis Pharma Raises €18 Million to Fight Charcot Disease

BioTech in Lyon wants to accelerate the development of its drug candidate in the fight against Charcot disease.

Read Full Article
usinenouvelle.comusinenouvelle.com

Axoltis Biotech Raises €18 Million to Advance Promising Treatment for Neurodegenerative Diseases

A specialist in neurodegenerative diseases, Axoltis Pharma will be able to advance the development of its only drug candidate, the NX210c. Based in Clermont-Ferrand, biotech raised €18 million during a round-table A, consisting of an increase in capital and participative financing.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

usinenouvelle.com broke the news in on Tuesday, December 2, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Biotech icon

Biotech

Clermont-Ferrand icon

Clermont-Ferrand

Health & Medicine icon

Health & Medicine

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal